Cargando…

Effectiveness and safety of Dupilumab for the treatment at 104 weeks of recalcitrant bullous pemphigoid

Detalles Bibliográficos
Autores principales:	Manzo Margiotta, Flavia, Fidanzi, Cristian, Bevilacqua, Matteo, Janowska, Agata, Romanelli, Marco, Manni, Elisabetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10549962/ https://www.ncbi.nlm.nih.gov/pubmed/37881049 http://dx.doi.org/10.1111/srt.13488

Ejemplares similares

Recalcitrant bullous pemphigoid responsive to dupilumab in an adolescent patient
por: Zhou, Albert E., et al.
Publicado: (2022)

Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2021)

Vegetative Skin Lesions in Patient with Bruton's Agammaglobulinemia
por: Fidanzi, Cristian, et al.
Publicado: (2023)

Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
por: Zhang, Yihua, et al.
Publicado: (2021)

Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
por: Wang, Si-Hang, et al.
Publicado: (2021)

Use of Dupilumab in Bullous Pemphigoid: Where Are We Now?
por: Russo, Roberto, et al.
Publicado: (2022)

Effect of Dupilumab on Generalized Verrucosis in Refractory Bullous Pemphigoid
por: WANG, Qijun, et al.
Publicado: (2023)

Recalcitrant infantile bullous pemphigoid successfully treated with cyclosporine
por: Bar-Ilan, Efrat, et al.
Publicado: (2022)

Trichoepithelioma and tattooing: a causal or casual relationship?
por: Fidanzi, Cristian, et al.
Publicado: (2023)

Idiopathic erythema annulare centrifugum successfully treated with doxycycline: A viable therapeutic option?
por: Fidanzi, Cristian, et al.
Publicado: (2023)

The Successful Treatment of COVID-19-Induced Bullous Pemphigoid With Dupilumab
por: Savoldy, Michelle A, et al.
Publicado: (2022)

Cutaneous Cytomegalovirus Infection Presenting As Recalcitrant Bullous Pemphigoid Lesion
por: Baek, Gayun, et al.
Publicado: (2023)

Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report
por: Pop, Samantha R., et al.
Publicado: (2022)

Ultra-High Frequency UltraSound (UHFUS) Assessment of Barrier Function in Moderate-to-Severe Atopic Dermatitis during Dupilumab Treatment
por: Dini, Valentina, et al.
Publicado: (2023)

Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review
por: Cao, Peng, et al.
Publicado: (2022)

Case report: Successful treatment of non-bullous lichen planus pemphigoides with dupilumab
por: Li, Si-Zhe, et al.
Publicado: (2022)

Successful Treatment of Psoriasis Combined with Bullous Pemphigoid with Dupilumab: A Case Report
por: Liu, Jing-Hua, et al.
Publicado: (2023)

Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types
por: Yan, Tianmeng, et al.
Publicado: (2023)

Bullous pemphigoid
por: Miyamoto, Denise, et al.
Publicado: (2019)

Concomitant use of dupilumab with glucocorticoid in bullous pemphigoid reduces disease severity: A preliminary study
por: Hu, Lingyu, et al.
Publicado: (2023)

Case Report: Omalizumab Successfully Treated Recalcitrant Bullous Pemphigoid in an Elderly Patient with Multiple Comorbidities
por: Liu, Jue, et al.
Publicado: (2022)

Bullous Pemphigoid and Other Pemphigoid Dermatoses
por: Pratasava, Valeryia, et al.
Publicado: (2021)

Recalcitrant course of bullous pemphigoid indicating coexisting hypereosinophilic syndrome: A case report and literature review
por: Ganji, Raziyeh, et al.
Publicado: (2023)

Pemphigoid gestationis treated with dupilumab
por: Chen, Rita E., et al.
Publicado: (2023)

Resolution in bullous pemphigoid
por: Sadik, Christian D., et al.
Publicado: (2019)

Esophageal Bullous Pemphigoid
por: Castelo Branco, Catarina, et al.
Publicado: (2022)

Dyshidrosiform Bullous Pemphigoid
por: Cohen, Philip R.
Publicado: (2021)

Cutaneous Dermatophytosis Mimicking Bullous Pemphigoid or Typical Bullous Pemphigoid and Tinea Incognito?
por: Andrés, Tirado-Sánchez, et al.
Publicado: (2019)

When Bullous Pemphigoid Is Not Bullous Pemphigoid: The Importance of Going Beyond Direct Immunofluorescence
por: Hopkins, Christina R, et al.
Publicado: (2022)

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases
por: Lamberts, Aniek, et al.
Publicado: (2018)

Dupilumab, an emerging therapeutic choice for recalcitrant subepidermal autoimmune bullous diseases: a case series of three patients
por: Liu, Xiuting, et al.
Publicado: (2022)

Ultra-High-Frequency Ultrasound as an Innovative Imaging Evaluation of Hyaluronic Acid Filler in Nasolabial Folds
por: Salvia, Giorgia, et al.
Publicado: (2023)

A rare association of bullous pemphigoid with mycosis fungoides and Sézary syndrome
por: Egger, Andjela, et al.
Publicado: (2020)

LOCALIZED FLEXURAL BULLOUS PEMPHIGOID
por: Mehta, Vandana, et al.
Publicado: (2008)

Coexistence of psoriasis with bullous pemphigoid
por: Rao, Raghavendra, et al.
Publicado: (2012)

Pembrolizumab-induced bullous pemphigoid
por: Sun, Christina W., et al.
Publicado: (2019)

Bullous pemphigoid associated with nintedanib
por: Hasson, Amelia M., et al.
Publicado: (2019)

Bullous Pemphigoid Mimicking Cellulitis
por: Ivyanskiy, Ilya, et al.
Publicado: (2021)

Semaglutide-associated bullous pemphigoid
por: Burruss, Clayton P., et al.
Publicado: (2021)

Bullous Pemphigoid Complicated by Sepsis
por: Shah, Dipal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l3beat3gc54u84nlq48fj2c97m